Publication | Closed Access

Rationale and Design of the Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST)

Heart FailureCardiovascular DiseaseAntihypertensive TherapyCardiovascular PharmacologyOutcomes ResearchPlacebo-controlled StudyPharmacotherapyCardiac CareCardiovascular FunctionMedicineCardiologyDiastolic FunctionVasopressin Antagonism